Maravai LifeSciences
MRVI
MRVI
150 hedge funds and large institutions have $313M invested in Maravai LifeSciences in 2025 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 57 increasing their positions, 44 reducing their positions, and 52 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
2.08% less ownership
Funds ownership: 92.15% → 90.07% (-2.1%)
18% less funds holding
Funds holding: 184 → 150 (-34)
62% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 52
Holders
150
Holding in Top 10
3
Calls
$1.85M
Puts
$133K
Top Buyers
| 1 | +$5.63M | |
| 2 | +$5.56M | |
| 3 | +$4.55M | |
| 4 |
TC
Tejara Capital
London,
United Kingdom
|
+$2.94M |
| 5 |
FPA
First Pacific Advisors
El Segundo,
California
|
+$1.56M |
Top Sellers
| 1 | -$7.84M | |
| 2 | -$4.79M | |
| 3 | -$2.37M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.77M |
| 5 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$1.46M |